All
Advanced precision microsampling for COVID-19 research
Download: Advanced precision microsampling for COVID-19 research [PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Brochure - hemaPEN
Download: Brochure - hemaPEN [PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Brochure - hemaPEN (research use only)
Download: Brochure - hemaPEN (research use only) [PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Brochure - hemaPEN (research use only) (Japanese)
Download: Brochure - hemaPEN (research use only) (Japanese) [PDF]
hemaPENは開発中でプロトタイプデバイスが研究、調査目的のみで供給可能です。このデバイスは医療または診断には使用できません。Class 1血液採取と補完デバイスとしてhemaPENの登録が2019年末に予定されています。
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Brochure - LEAP CHRONECT Quantos integrated powder-liquid automation system
The high-precision, safe and reliable powder automation you’ve always wanted
Download: Brochure - LEAP CHRONECT Quantos integrated powder-liquid automation system [PDF]
View full product details
Brochure - SARS-CoV-2 serology testing
Post-approval efficacy surveillance
Download: Brochure - SARS-CoV-2 serology testing [PDF]
The Synexa assay kit is supplied for research purposes only. Not for therapeutic or diagnostic use.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Brochure - Septa, caps and liners (portfolio and capabilities)
Download: Brochure - Septa, caps and liners (portfolio and capabilities) [PDF]
Also see: Brochure - Septa, caps and liners (product information and part numbers)
View full product details
Brochure - Septa, caps and liners (product information and part numbers)
Download: Brochure - Septa, caps and liners (product information and part numbers) [PDF]
Also see: Brochure - Septa, caps and liners (portfolio and capabilities)
Also see: Brochure - GC consumables
View full product details
Instructions for use - hemaPEN
Download: Instructions for use - hemaPEN [PDF]
Also see: Video - Instructional video for hemaPEN use
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Instructions for use - hemaPEN (research use only)
Download: Instructions for use - hemaPEN (research use only) [PDF]
Also see: Video - Instructional video for hemaPEN use (research use only)
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Instructions for use - hemaPEN opening tool
Download: Instructions for use - hemaPEN opening tool [PDF]
The opening tool can only be used in conjunction with Trajan’s hemaPEN. The hemaPEN opening tool has been designed to assist in the retrieval of the dried blood spot samples from internal body of hemaPEN.
View full product details
Part Number List - hemaPEN
Download: Part Number List - hemaPEN [PDF]
Also see: Product Data Sheet - hemaPEN
Find in table:
| Part number | Part description and detail |
|---|---|
| 498100000 | hemaPEN D300S |
| 498100010 | hemaPEN W300S |
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Part Number List - hemaPEN (research use only)
Download: Part Number List - hemaPEN (research use only) [PDF]
Also see: Product Data Sheet - hemaPEN (research use only)
Find in table:
| Part number | Part description and detail |
|---|---|
| 498100001 | hemaPEN D300S RUO |
| 498100011 | hemaPEN W300S RUO |
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Poster - Blood sampling made easy
Download: Poster - Blood sampling made easy [PDF]
Author: Australian National Fabrication Facility (ANFF).
View full product details
Product Data Sheet - hemaPEN
Download: Product Data Sheet - hemaPEN [PDF]
Also see: Part Number List - hemaPEN
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Product Data Sheet - hemaPEN (research use only)
Download: Product Data Sheet - hemaPEN (research use only) [PDF]
Also see: Part Number List - hemaPEN (research use only)
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Product Specification Sheet - hemaPEN
Download: Product Specification Sheet - hemaPEN [PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Product Specification Sheet - hemaPEN (research use only)
Download: Product Specification Sheet - hemaPEN (research use only)[PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Quick guide - hemaPEN
Download: Quick guide - hemaPEN [PDF]
Also see: Quick guide translations - hemaPEN
Also see: Instructions for use - hemaPEN
Also see: Video - Instructional video for hemaPEN use
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Quick guide - hemaPEN (research use only)
Download: Quick guide - hemaPEN (research use only) [PDF]
Also see: Instructions for use - hemaPEN use (research use only)
Also see: Video - Instructional video for hemaPEN use (research use only)
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Quick guide translations - hemaPEN
Download: Quick guide translations - hemaPEN [PDF]
Languages:
- Bulgarian/български (BG)
- Croatian/Hrvatski (HR)
- Czech/čeština (CS)
- Danish/Dansk (DA)
- Dutch/Nederlands (NL)
- Estonian/Eesti keel (ET)
- French/Français (FR)
- German/Deutsch (DE)
- Greek/Ελληνικά (EL)
- Hungarian/Magyar (HU)
- Italian/Italiano (IT)
- Latvian/Latviešu valoda (LV)
- Lithuanian/Lietuvių kalba (LT)
- Norwegian/Norsk (NO)
- Polish/Polski (PL)
- Portuguese/Português (PT)
- Romanian/Română (RO)
- Slovak/Slovenčina (SK)
- Slovene/Slovenščina (SL)
- Spanish/Español (ES)
- Swedish/Svenska (SV)
Also see: Quick guide - hemaPEN
Also see: Instructions for use - hemaPEN
Also see: Video - Instructional video for hemaPEN use
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Technical Poster - Collection and storage of volumetrically accurate and precise dried blood spots in a contained device: hemaPEN
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Technical Poster - Improved dried blood spot-based metabolomics using a novel microsampling device
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490.
Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Technical Poster - Incorporating novel synthetic DBS substrates into a blood microsampling device for multi-omics analyses
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
